Rheumatology Clinical Trials

PharmaNet’s rheumatology team has extensive experience in standard scales for osteoarthritis and in developing treatment options for osteoarthritis, rheumatoid arthritis, osteoporosis, and undifferentiated connective tissue disease. PharmaNet has conducted 36 arthritis trials studying close to 25,000 subjects at approximately 2,553 sites in the treatment of rheumatoid arthritis and osteoarthritis. Studies have included a variety of treatments, administered orally or via injection (intrarticular, subcutaneous, and intravenous).

PharmaNet’s large network of experienced investigators provides timely recruitment for rheumatology studies.